JP2022533991A5 - - Google Patents
Info
- Publication number
- JP2022533991A5 JP2022533991A5 JP2021568962A JP2021568962A JP2022533991A5 JP 2022533991 A5 JP2022533991 A5 JP 2022533991A5 JP 2021568962 A JP2021568962 A JP 2021568962A JP 2021568962 A JP2021568962 A JP 2021568962A JP 2022533991 A5 JP2022533991 A5 JP 2022533991A5
- Authority
- JP
- Japan
- Prior art keywords
- gly
- leu
- ala
- gln
- hyp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2019-0059628 | 2019-05-21 | ||
| KR20190059628 | 2019-05-21 | ||
| PCT/KR2020/006594 WO2020235932A1 (ko) | 2019-05-21 | 2020-05-20 | 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022533991A JP2022533991A (ja) | 2022-07-27 |
| JP2022533991A5 true JP2022533991A5 (https=) | 2023-05-25 |
| JP7576048B2 JP7576048B2 (ja) | 2024-10-30 |
Family
ID=73458705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568962A Active JP7576048B2 (ja) | 2019-05-21 | 2020-05-20 | 新規なペプチド化合物またはその薬学的に許容される塩 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US12428446B2 (https=) |
| EP (2) | EP3974441B1 (https=) |
| JP (1) | JP7576048B2 (https=) |
| KR (2) | KR20200134175A (https=) |
| CN (1) | CN114269769B (https=) |
| AU (1) | AU2020277930B2 (https=) |
| BR (1) | BR112021023477A2 (https=) |
| CA (1) | CA3139411A1 (https=) |
| ES (1) | ES3012499T3 (https=) |
| MX (1) | MX2021014051A (https=) |
| MY (1) | MY205382A (https=) |
| PL (1) | PL3974441T3 (https=) |
| SG (1) | SG11202112276RA (https=) |
| WO (1) | WO2020235932A1 (https=) |
| ZA (1) | ZA202109175B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021023477A2 (pt) | 2019-05-21 | 2022-02-15 | Eyebio Korea | Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório |
| KR102593936B1 (ko) * | 2021-12-13 | 2023-10-27 | 주식회사 아이바이오코리아 | 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물 |
| EP4450079A4 (en) * | 2021-12-13 | 2025-12-10 | Eyebiokorea Inc | COMPOSITION FOR THE TREATMENT OF MACULAR DEGENERATION COMPRISING A NEW PEPTIDE |
| KR20230089987A (ko) | 2021-12-14 | 2023-06-21 | 주식회사 아이바이오코리아 | 펩타이드 약물을 포함하는 안구 투여용 약학 조성물 |
| WO2023224454A1 (ko) | 2022-05-20 | 2023-11-23 | 주식회사 엘지화학 | 양극 활물질 및 이의 제조방법 |
| KR102587729B1 (ko) | 2023-02-27 | 2023-10-12 | 주식회사 아이바이오코리아 | 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물 |
| KR102728422B1 (ko) * | 2024-05-27 | 2024-11-11 | 주식회사 아이바이오코리아 | 염증성 질환의 치료 효과를 갖는 신규한 펩타이드 및 이의 용도 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5084555A (en) | 1989-08-21 | 1992-01-28 | The Administrators Of The Tulane Educational Fund | An octapeptide bombesin analog |
| IT1241761B (it) * | 1990-08-03 | 1994-02-01 | Menarini Farma Ind | Peptidi di sintesi antagonisti della neurochinina a, loro sali e relativi procedimenti di fabbricazione |
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| WO2004074312A2 (en) * | 2003-02-05 | 2004-09-02 | University Of Ulster | Tryptophyllin peptides and uses thereof |
| NZ577196A (en) | 2005-01-20 | 2011-06-30 | Biomarck Pharmaceuticals Ltd | Mucin hypersecretion inhibitors based on the structure of MANS and methods of use |
| US8378070B2 (en) | 2007-03-12 | 2013-02-19 | Ramot At Tel-Aviv University Ltd. | Peptides for the regulation of neurotransmitter sequestration and release |
| AU2008297541A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| US20090074672A1 (en) | 2007-09-17 | 2009-03-19 | Sri International | Tumor Boundary Imaging |
| JP5299956B2 (ja) | 2008-09-29 | 2013-09-25 | 国立大学法人東北大学 | 質量分析装置を用いた代謝酵素群の一斉タンパク質定量に用いるペプチド |
| WO2011060349A1 (en) | 2009-11-13 | 2011-05-19 | North Carolina State University | Methods of modulating mesenchymal stem cells |
| CA2869599C (en) * | 2012-04-13 | 2021-07-27 | Lubrizol Advanced Materials, Inc. | Compounds which inhibit neuronal exocytosis (ii) |
| WO2013158230A1 (en) | 2012-04-19 | 2013-10-24 | The Regents Of The University Of California | Compositions and methods for detecting unstable arteriosclerotic plaques |
| KR101438744B1 (ko) | 2012-08-02 | 2014-09-15 | 전남대학교산학협력단 | 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물 |
| KR101721059B1 (ko) | 2014-12-26 | 2017-03-30 | 주식회사 아이바이오코리아 | 안구 표면 질환 예방 또는 치료용 약학조성물 |
| KR101810163B1 (ko) | 2016-04-08 | 2018-01-25 | 주식회사 아이바이오코리아 | 안구 표면질환 예방 또는 치료용 약학조성물 |
| KR101798183B1 (ko) * | 2016-04-08 | 2017-11-15 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| EP3539559B1 (en) | 2016-04-08 | 2020-08-26 | Eyebio Korea | Collagen type ii alpha-1-based peptide for use in the treatment of macular degeneration |
| KR101795650B1 (ko) | 2016-05-12 | 2017-11-09 | 인제대학교 산학협력단 | 아플리버셉트-콜라겐 타입 ii 펩타이드의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| KR101795653B1 (ko) | 2016-05-19 | 2017-11-09 | 인제대학교 산학협력단 | 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| JP2019524673A (ja) * | 2016-06-28 | 2019-09-05 | バロリゼーション−ルシェルシュ，リミテッド パートナーシップ | 新規な環状ペプチドおよびその使用 |
| HUP1700012A2 (en) * | 2017-01-06 | 2018-07-30 | Evolveritas Kft | Novel proteins and use thereof |
| EP3609519B1 (en) * | 2017-04-11 | 2025-11-26 | University of Maryland, Baltimore | Compositions and methods for treating inflammation and cancer |
| RU2766160C2 (ru) * | 2017-05-17 | 2022-02-08 | Юю Фарма, Инк. | Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента |
| CN107814840B (zh) * | 2017-12-12 | 2020-04-10 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽pkypvepf及其制备方法和应用 |
| CN108727472A (zh) * | 2018-06-07 | 2018-11-02 | 南方医科大学 | 带负电荷的细胞穿透肽及作为细胞内运送载体的用途 |
| TWI865470B (zh) | 2018-11-14 | 2024-12-11 | 南韓商柳柳製藥股份有限公司 | 治療眼睛疾病之肽及醫藥組合物 |
| BR112021023477A2 (pt) | 2019-05-21 | 2022-02-15 | Eyebio Korea | Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório |
-
2020
- 2020-05-20 BR BR112021023477A patent/BR112021023477A2/pt unknown
- 2020-05-20 KR KR1020200060397A patent/KR20200134175A/ko not_active Ceased
- 2020-05-20 JP JP2021568962A patent/JP7576048B2/ja active Active
- 2020-05-20 PL PL20808771.8T patent/PL3974441T3/pl unknown
- 2020-05-20 AU AU2020277930A patent/AU2020277930B2/en active Active
- 2020-05-20 EP EP20808771.8A patent/EP3974441B1/en active Active
- 2020-05-20 CN CN202080037370.6A patent/CN114269769B/zh active Active
- 2020-05-20 WO PCT/KR2020/006594 patent/WO2020235932A1/ko not_active Ceased
- 2020-05-20 ES ES20808771T patent/ES3012499T3/es active Active
- 2020-05-20 CA CA3139411A patent/CA3139411A1/en active Pending
- 2020-05-20 MX MX2021014051A patent/MX2021014051A/es unknown
- 2020-05-20 US US17/613,176 patent/US12428446B2/en active Active
- 2020-05-20 SG SG11202112276RA patent/SG11202112276RA/en unknown
- 2020-05-20 EP EP24210365.3A patent/EP4483959A3/en active Pending
- 2020-05-20 MY MYPI2021006829A patent/MY205382A/en unknown
-
2021
- 2021-11-17 ZA ZA2021/09175A patent/ZA202109175B/en unknown
-
2022
- 2022-04-29 KR KR1020220053844A patent/KR102523943B1/ko active Active
-
2024
- 2024-06-27 US US18/756,527 patent/US20240352071A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022533991A5 (https=) | ||
| AU2021203223A1 (en) | Stabilized anti-microbial peptides | |
| JP2022546609A5 (https=) | ||
| US10357589B2 (en) | One component fibrin glue comprising a polymerization inhibitor | |
| JP2022513223A5 (https=) | ||
| EP2311851A3 (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | |
| JP2023537951A5 (https=) | ||
| RU2019141646A (ru) | Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента | |
| HRP20240906T1 (hr) | Agonisti crf2 receptora i njihova primjena u terapiji | |
| JP2020520372A5 (https=) | ||
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| AU2020268578B2 (en) | MASP inhibitory compounds and uses thereof | |
| CY1107990T1 (el) | Τριπεπτιδια και παραγωγα τριπεπτιδιων για τη θepαπεια νευροεκφυλιστικων ασθενειων | |
| EA201100459A1 (ru) | Композиции, включающие интерлейкин-1 и пептиды | |
| JP2012524775A5 (https=) | ||
| JP2005501068A5 (https=) | ||
| JP2003286168A5 (https=) | ||
| IL299778A (en) | Therapeutic use of glucagon derivative or conjugate thereof for liver disease | |
| RU2021133737A (ru) | Новое пептидное соединение или его фармацевтически приемлемая соль | |
| JP2018516916A5 (https=) | ||
| TH2101007159A (th) | สารประกอบเปปไทด์ชนิดใหม่หรือเกลือซึ่งเป็นที่ยอมรับทางเภสัชกรรมของสิ่งนี้ | |
| GB0717526D0 (en) | Improvements in or relating to compositions for the treatment or prophylaxis of viral infections | |
| RU2003126176A (ru) | Кислотно-аддитивные соли тербинафина и яблочной кислоты | |
| RU2840441C2 (ru) | Соединения, ингибирующие masp, и их применения | |
| RU2025104667A (ru) | Ингибиторы il-15, применимые для лечения атопического дерматита |